Kampala, Uganda | THE INDEPENDENT | Cipla Quality Chemicals Limited has reported a substantial 74% dip in profit after tax to Shs 3.56 billion for the six months ending September 30. The dip is attributed to a significant increase in operating expenses and a shift in the product mix. The company’s …
Read More »Cipla issues profit warning amidst product mix changes
Kampala, Uganda | THE INDEPENDENT | Uganda’s drug manufacturer, Cipla Quality Chemicals Ltd, has issued a profit warning for the six months period ended Sept.202, 2023, citing changes in product mix. The Uganda Securities Exchange-listed firm now expects to report lower net earnings than what it reported during the same period …
Read More »Cipla profit after tax reduce by 21% to Shs 18.9bn
But directors have recommended a dividend of Shs2.5 per share payable in September this year which is higher than Shs2 per share paid last year. Kampala, Uganda | JULIUS BUSINGE | Pharmaceutical manufacturing company Cipla Quality Chemical Industries Limited has reported a 21% decline in profit after tax from Shs24bn in …
Read More »Cipla to sell majority stake in the local subsidiary
The stake sale in Cipla Quality Chemical Industries Ltd can fetch $25-30 million Kampala, Uganda | AGENCIES | Cipla Ltd.’s wholly owned subsidiaries have entered into an agreement with investment management company Africa Capitalworks SSA 3 to sell 51.18% stake in a Ugandan subsidiary. The two subsidiaries, Cipla (EU) Ltd …
Read More »Ugandan manufacturers producing 20 percent of essential medicines: Experts
Kampala, Uganda | THE INDEPENDENT | Ugandan manufacturers still produce very low quantities of essential medicines catering for only about 20 percent of the country’s demand. Speaking at a meeting organized by the Uganda Healthcare Federation, Nevin Bradford, the former CEO of Cipla Quality Chemicals Company said currently, there are over …
Read More »Cipla’s profits rises fivefold to Shs 13.9billion
The company manufactures antiretrovirals, artemisinin-based combination therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, malaria and Hepatitis | THE INDEPENDENT | Cipla Qaulity Chemicals Ltd, the East African nation’s drug manufacturer, has said net profits surged nearly five times to Shs 13.9 billion for the six months ending September driven …
Read More »Cipla to pay shareholders dividend worth Shs 7.3billion
The company recorded the first profit since listing on Uganda Securities Exchange in 2018 | THE INDEPENDENT | Cipla Quality Chemical Industries has reported a better performance for the period ended March 31, 2022, posting a net profit of Shs24bn compared to a loss of Shs10bn in 2020. This performance …
Read More »Cipla’s CEO projects good returns for shareholders
The company is in the process of formulating a strategy to enable it achieve short term and long-term goals Kampala, Uganda | THE INDEPENDENT | Shareholders of Cipla Quality Chemical Industries Limited (CQCIL) are waiting to see how their company performs during the reign of the new chief executive officer …
Read More »Cipla recovers 5.6% of Zambian debt worth Shs 42.9bn
The company recorded Shs 2.8billion profit for the half year period Kampala, Uganda | ISAAC KHISA | Uganda’s drug manufacturer, Cipla Quality Chemicals Ltd, recovered Shs 2.5billion from the Zambian government for the drugs supplied in 2018, helping the company to record a profit from the second time since listing …
Read More »No dividend for Cipla shareholders
The company’s trading price has tumbled to less than Shs100 per share, down from Shs 256.5 IPO level Kampala, Uganda | ISAAC KHISA | Shareholders of drug maker, Cipla Quality Chemicals Ltd will not earn a dividend for the second consecutive year even after reporting a more than 50% drop …
Read More »